Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial.

The Oncologist
Satoshi OizumiToshihiro Nukiwa

Abstract

For non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations, first-line gefitinib produced a longer progression-free survival interval than first-line carboplatin plus paclitaxel but did not show any survival advantage in the North East Japan 002 study. This report describes the quality of life (QoL) analysis of that study. Chemotherapy-naïve patients with sensitive EGFR-mutated, advanced NSCLC were randomized to receive gefitinib or chemotherapy (carboplatin and paclitaxel). Patient QoL was assessed weekly using the Care Notebook, and the primary endpoint of the QoL analysis was time to deterioration from baseline on each of the physical, mental, and life well-being QoL scales. Kaplan-Meier probability curves and log-rank tests were employed to clarify differences. QoL data from 148 patients (72 in the gefitinib arm and 76 in the carboplatin plus paclitaxel arm) were analyzed. Time to defined deterioration in physical and life well-being significantly favored gefitinib over chemotherapy (hazard ratio [HR] of time to deterioration, 0.34; 95% confidence interval [CI], 0.23-0.50; p < .0001 and HR, 0.43; 95% CI, 0.28-0.65; p < .0001, respectively). QoL was maintained much longer in patien...Continue Reading

References

Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaJ Pater
Nov 3, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K KobayashiK Yoshida
Mar 2, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·H FumimotoS Kudoh
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Jan 22, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·David OsobaUNKNOWN Quality of Life Committee of the NCIC CTG
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David CellaRonald B Natale
Jul 27, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Kunihiko KobayashiShoji Kudoh
Jun 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueToshihiro Nukiwa
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea BezjakUNKNOWN National Cancer Institute of Canada Clinical Trials Group Study BR.21
Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Riichiroh MaruyamaMasahiro Fukuoka
Feb 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira InoueUNKNOWN North East Japan Gefitinib Study Group
Jun 18, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoshi MoritaToshihiro Nukiwa
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dae Ho LeeSang-We Kim
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Oct 21, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sumitra ThongprasertMasahiro Fukuoka
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T

❮ Previous
Next ❯

Citations

Sep 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A InoueUNKNOWN North-East Japan Study Group
Jul 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ZhouUNKNOWN OPTIMAL investigators
Jun 21, 2013·Cancer Management and Research·Hiroyasu KanedaIsamu Okamoto
Jan 18, 2013·The Keio Journal of Medicine·Yasunari Takada, Koichi Matsuo
Jul 11, 2013·Future Oncology·Hsiang-Fong KaoJames Chih-Hsin Yang
Jan 20, 2015·Expert Opinion on Pharmacotherapy·Naoto MorikawaUNKNOWN North-East Japan Study Group
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Masayuki TakedaKazuhiko Nakagawa
Aug 17, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Makoto MaemondoAkihiko Gemmah
Jan 23, 2016·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Katsuya WatanabeMunetaka Masuda
Sep 3, 2013·Cancer Science·Takashi KohnoKoichi Goto
Dec 3, 2014·Respiratory Investigation·Yuko KawanoYoichi Nakanishi
May 16, 2015·Cancer Metastasis Reviews·Stefan Zimmermann, Solange Peters
Jan 1, 2015·Nature Reviews. Disease Primers·Cesare GridelliRafael Rosell
Feb 12, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SugawaraUNKNOWN North East Japan Study Group and Tokyo Cooperative Oncology Group
May 6, 2015·Cancer Treatment Reviews·G V ScagliottiJ F Vansteenkiste
Sep 25, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yoshifumi MatsumotoUNKNOWN North-East Japan Study Group
Sep 13, 2016·International Journal of Molecular Sciences·Vid MlakarMarc Ansari
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James Chih-Hsin YangLecia V Sequist
Sep 2, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory A MastersUNKNOWN American Society of Clinical Oncology Clinical Practice
Jan 18, 2018·The Cochrane Database of Systematic Reviews·Esther Ha SimKwun M Fong
Oct 11, 2014·World Journal of Clinical Oncology·Kazuhiro Asami, Shinji Atagi
May 26, 2016·The Cochrane Database of Systematic Reviews·Janette GreenhalghJohn A Green
May 3, 2019·International Journal of Clinical Oncology·Hiroaki AkamatsuNobuyuki Yamamoto
May 10, 2020·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Katsuya WatanabeMunetaka Masuda
Aug 14, 2020·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Akira Inoue
Apr 30, 2017·Epidemiologic Reviews·Thomas M AtkinsonEthan Basch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.